Pharma News - Chemdiv

Doesn't an excessive intake of simple sugar affect higher brain function?

There has been a remarkable increase in intake of simple sugar (sucrose, isomerized sugar (corn syrup)) from beverages and diets in modern society.

Merck & Ridgeback’s Molnupiravir Receives Special Emergency Approval in Japan

Global pharmaceutical major Merck & Co., Inc. (NYSE:MRK) recently revealed that its investigational, orally administered antiviral medicine for treatment of COVID-19, molnupiravir, has been gra...

Researchers discover antibodies that neutralize omicron and other SARS-CoV-2 variants

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants.

Faraday Pharmaceuticals Announces Publication of Results from its Phase 2 Study of FDY-5301 for the Treatment of Reperfusion Injury Following a STEMI Heart Attack

Faraday Pharmaceuticals, Inc., a muscle health-focused biopharmaceutical company developing therapeutics to treat patients experiencing potentially life changing critical illness, announced today t...

Novavax say their vaccines are effective against Omicron

WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.

FDA grants fast track designation to Eisai-Biogen’s Alzheimer’s therapy

The US Food and Drug Administration (FDA) has granted Fast Track designation to Eisai and Biogen’s experimental drug, lecanemab, to treat early Alzheimer’s disease (AD). ...

2022 Forecast: Biopharma's COVID response next year

Remember the uncertainty the COVID-19 pandemic posed?

U.S. Army reports progress on COVID vaccine that fights all variants

The U.S. Army says it has developed a COVID-19 vaccine it believes could work against any and all coronavirus variants, including Omicron.

FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with pos...

FDA Authorizes First Oral Antiviral for Treatment of COVID-19

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treat...

Eight substances added to 15th Report on Carcinogens

Eight substances have been added to the Report on Carcinogens, bringing the total list to 256 substances that are known, or reasonably anticipated, to cause cancer in humans. ...

Ketamine therapy swiftly reduces depression and suicidal thoughts

Ketamine therapy has a swift short-term effect on reducing symptoms of depression and suicidal thoughts, according to a review of all the available evidence.